SRRKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Scholar Rock Holding Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$40.24+0.34 (+0.85%)

Close on Oct 19, 2026

Market cap: $5.26B
P/E (TTM): –
Dividend yield: –

Scholar Rock Holding Corp cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30
Depreciation & Amortization	0.30	0.34	0.43	0.42	0.42	0.39	0.40	0.45	0.50	0.60	0.67	0.71	0.73	0.73	0.75	0.74	0.74	0.75	0.73	0.67	0.64	0.59	0.32	0.39	0.39	0.39	0.39	0.33	0.32	0.27	0.24	0.21	0.18	0.18	0.17	0.17	–
Stock-Based Compensation	20	18	19	18	24	13	9.50	9.65	9.31	8.16	6.95	7.20	6.82	6.17	6.17	7.92	6.79	6.83	6.10	6.15	6.23	4.67	2.53	4.04	2.40	2.21	1.85	2.69	1.81	1.62	2.15	1.49	1.09	0.48	0.79	0.20	0.23
Other Non-Cash Items	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-0.01	–	–	–	0	–
Change in Accounts Receivable	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	25	–	–	–	–	–	–	–	–	–	–	–
Change in Accounts Payable	1.75	-1.09	3.54	5.66	-3.33	-5.66	6.02	0.76	0.46	-0.61	1.50	-1.08	-0.68	-0.27	1.99	-0.85	0.19	-1.58	2.21	0.59	-0.55	-1.23	2.13	-1.57	0.45	1.09	-0.68	0.36	-0.93	-0.10	1.37	-0.17	-1.07	1.53	-1.02	1.02	–
Change in Unearned Revenue	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	0	-33	-4.05	-5.46	-4.60	-4.71	-3.44	-3.04	-3.90	-5.03	17	-4.77	-5.04	-3.11	–	–	–	–	–	–	–
Operating Cash Flow	-70	-82	-75	-69	-77	-79	-50	-52	-49	-50	-37	-32	-33	-43	-29	-26	-35	-43	-32	-36	-32	-27	-20	-23	-20	2.64	-16	-15	-16	-16	55	-9.01	-12	-9.88	-6.06	-5.75	–
Capital Expenditures	0.00	-0.07	-0.03	-0.08	-0.22	-0.27	-0.02	-0.03	-0.02	-0.02	0	0	-0.04	-0.03	-0.12	-0.03	-0.48	-0.44	-0.54	-1.41	-0.98	-2.31	-1.97	-1.83	-0.07	-0.21	-1.47	-0.37	-0.60	-0.68	-0.70	-0.60	-0.02	-0.18	-0.11	-0.04	–
Sale of Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	0	0	0	0.01	–	–	–	–	–	–	–	–	–	–	–	–	0	–	–	–	–	–	–	–	–	–	–
Purchase of Investments	-43	-25	0	-19	-21	-58	-210	-14	-33	-35	-104	-81	–	–	-9.81	-211	0.00	-80	0	-30	0	-30	-121	-60	0	-19	-41	-117	0	-77	–	–	–	-23	–	–	–
Sale & Maturity of Investments	38	20	39	79	107	93	15	50	84	68	79	73	90	90	10	65	45	10	30	35	80	55	0	26	39	76	63	46	22	46	15	0.00	–	–	6.01	9.01	–
Investing Cash Flow	-5.50	-5.34	39	60	85	35	-195	35	51	33	-25	-8.47	-15	90	0.08	-146	45	-71	29	3.28	79	23	-123	-36	39	56	21	-72	21	-32	-61	-0.60	25	-24	5.90	8.98	–
Stock Issued	63	98	0.00	92	–	–	–	–	–	–	92	0	4.40	0.83	0	-0.46	–	–	–	–	–	–	–	–	–	–	-0.05	6.13	–	–	17	78	78	–	–	–	–
Debt Issued	-197	197	0	0	0.00	25	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Debt Repaid	0	-103	0	0	0	-26	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	-0.20	-0.17	-0.17	-0.17	-0.17	-0.17	–	-0.17	–
Other Financing Activities	–	–	–	0	0	0.00	–	–	–	–	0	0	0.00	0.00	–	–	–	–	0.00	-0.01	0.00	-0.01	0.00	-0.01	0.00	-0.01	0.00	0.00	0.00	0.00	0.00	–	–	–	–	–	–
Financing Cash Flow	83	194	73	144	6.47	4.17	346	0.17	-0.03	6.53	97	0.28	4.69	1.08	-0.97	-0.45	196	0.48	40	1.91	0.61	2.74	246	0.37	0.60	0.40	0.82	6.12	42	-0.16	17	-1.46	79	-0.17	47	-0.17	–
Foreign Exchange Rate Adjustments	-0.76	0.67	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Change in Cash	–	–	–	135	15	-40	101	-17	1.39	-9.88	34	-40	-43	48	-30	-173	206	-113	37	-31	48	-1.25	104	-59	20	59	5.96	-81	47	-48	11	-11	92	-34	47	3.06	–
Free Cash Flow	-70	-82	-76	-69	-77	-79	-50	-52	-49	-50	-37	-32	-33	-43	-29	-27	-35	-43	-33	-37	-33	-29	-22	-25	-20	2.43	-18	-15	-17	-16	54	-9.61	-12	-10	-6.17	-5.78	–
Interest Paid	2.03	2.37	2.03	1.28	1.26	1.50	1.61	1.67	1.67	1.66	1.66	1.65	1.60	1.49	1.34	1.20	1.02	0.81	0.59	0.50	0.50	0.49	–	–	–	–	–	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -123.1%

Financial strength

Current ratio: 7.02
Debt to equity: 0.77
Debt to assets: 37.5%
Cash to current liabilities: 605.0%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 20.71
Dividend yield: –